Physician profile
Daniela J Schupp
NPI 1215103692
$2,442.01
in general payments reported to CMS, 2019-2025
5 companies · $6.68 in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2020: $38.79 · 2021: $18.22 · 2022: $1,741 · 2023: $637 · 2025: $6.68.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Travel and Lodging: $507 · Food and Beverage: $137.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Travel and Lodging | $506.90 |
| Food and Beverage | $136.98 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Intuitive Surgical, INC. | $1,747.80 | 2022-2025 | |
| Stryker Corporation | $506.90 | 2023 | 1688 |
| Molli Surgical (US) INC | $130.30 | 2023 | |
| Tela Bio, INC. | $38.79 | 2020 | |
| Myriad Genetic Laboratories, INC. | $18.22 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Daniela Schupp listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.